Literature DB >> 3449477

Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group.

S Kramer1, R D Gelber, J B Snow, V A Marcial, L D Lowry, L W Davis, R Chandler.   

Abstract

Between March 1973 and June 1979, patients with advanced operable squamous cell carcinoma of the supraglottic larynx or hypopharynx were randomly allocated to receive either preoperative radiation therapy (5,000 rad) or postoperative radiation therapy (6,000 rad). Patients with oral cavity or oropharynx lesions were randomly assigned either preoperative radiation, postoperative radiation, or definitive radiation therapy (6,500-7,000 rad), with surgery reserved for salvage if residual disease was present 6 weeks after completion of irradiation. Three hundred twenty patients were evaluable with a median follow-up of 60 months. Based on results in 277 patients across all four regions combined, locoregional control was significantly better for patients assigned to receive postoperative radiation therapy (65%) compared with those assigned to receive preoperative radiation therapy (48%, P = 0.04). This was due to a higher rate of both persistent and recurrent local and regional disease in the preoperative group. Survival also showed a trend to be better in the postoperative group (38%) compared with the preoperative group (33%, P = 0.10). Rates of severe surgical and radiation therapy complications were similar overall. Forty-three patients were evaluable for each of the three treatment regimens assigned to patients with oral cavity or oropharynx lesions. Due to the small number of patients available for this portion of the trial, the observed differences for overall survival (4-year percentage 33% overall; 30% preoperative, 36% postoperative, 33% definitive radiation therapy) and for locoregional control (45% overall; 43% preoperative, 52% postoperative, 38% definitive radiation therapy) were not statistically significant. The use of definitive radiation therapy with surgical rescue as an ethically justified alternative treatment for these tumors remains a question for further research.

Entities:  

Mesh:

Year:  1987        PMID: 3449477     DOI: 10.1002/hed.2890100105

Source DB:  PubMed          Journal:  Head Neck Surg        ISSN: 0148-6403


  39 in total

Review 1.  Adjuvant treatment of locally-advanced head and neck tumours.

Authors:  Victoria Reyes López; Begoña Navalpotro Yagüe
Journal:  Clin Transl Oncol       Date:  2005-06       Impact factor: 3.405

Review 2.  Treatment of advanced neck metastases.

Authors:  G Spriano; R Pellini; V Manciocco; P Ruscito
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-12       Impact factor: 2.124

Review 3.  Head and neck cancer: an evolving treatment paradigm.

Authors:  David M Cognetti; Randal S Weber; Stephen Y Lai
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

4.  (Chemo)radiotherapy after laser microsurgery and selective neck dissection for pN2 head and neck cancer.

Authors:  Hendrik Andreas Wolff; Friedrich Ihler; Nina Zeller; Christian Welz; Klaus Jung; Martin Canis; Wolfgang Steiner
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-12       Impact factor: 2.503

5.  A comparison of concurrent cisplatin versus cetuximab with radiotherapy in locally-advanced head and neck cancer: A bi-institutional analysis.

Authors:  William A Stokes; Whitney A Sumner; Kiersten L Breggren; John T Rathbun; David Raben; Jessica D McDermott; Gregory Gan; Sana D Karam
Journal:  Rep Pract Oncol Radiother       Date:  2017-08-02

Review 6.  Postoperative Treatment of Oropharyngeal Cancer in the Era of Human Papillomavirus.

Authors:  Jessica L Geiger; Jamie A Ku
Journal:  Curr Treat Options Oncol       Date:  2019-02-15

Review 7.  Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives.

Authors:  Ari J Rosenberg; Everett E Vokes
Journal:  Oncologist       Date:  2020-09-21

8.  Retrospective analysis of the treatment results for patients with squamous cell carcinoma of tonsil.

Authors:  Ah Ram Chang; Hong-Gyun Wu; Charn Il Park; Kwang-Hyun Kim; Myung-Whun Sung; Dae-Seog Heo
Journal:  Cancer Res Treat       Date:  2005-04-30       Impact factor: 4.679

9.  A phase I clinical trial of prolonged infusion of hydroxyurea in combination with hyperfractionated, accelerated, external radiation therapy in patients with advanced squamous cell cancer of the head and neck.

Authors:  J J Beitler; R V Smith; H Haynes; C E Silver; A Quish; T Kotz; M Serrano; A Brook; S Wadler
Journal:  Invest New Drugs       Date:  1998       Impact factor: 3.850

10.  Long-term survival of patients with stage IV hypopharyngeal cancer: impact of fundus rotation gastroplasty.

Authors:  Martin K Schilling; Martin Eichenberger; Christoph A Maurer; Richard Greiner; Peter Zbären; Markus W Büchler
Journal:  World J Surg       Date:  2002-02-25       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.